A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

996 views

⸱

DOI:

10.3791/69880

⸱

December 30th, 2025

 ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

This protocol provides a detailed approach to assessing m6A modification levels of specific RNA using MeRIP-qPCR.

Abstract

RNA epitranscriptomic modification plays a critical role in the initiation and development of various cancers, among which N6-methyladenosine (m6A) is the most prevalent and functionally diverse modification. Here, we present a streamlined and reproducible protocol using MeRIP-qPCR to assess m6A modification levels of specific transcripts in osteosarcoma cells. In this assay, total RNA was extracted, followed by incubation with a specific anti-m6A antibody to immunocapture RNA of m6A modification. Then, RNA was fragmented, and enrichment of m6A-modified RNA fragments was achieved using protein G magnetic beads. The enriched RNA was released by proteinase K digestion and purified by RNA-binding beads. Lastly, RNA was subjected to reverse transcription and quantitative polymerase chain reaction (PCR) to assess m6A levels in candidate genes. The results have demonstrated that this method effectively distinguishes methylation differences and provides a reliable tool for exploring the functional mechanisms of m6A modification in osteosarcoma cells. In conclusion, MeRIP-qPCR offers a simple and highly specific approach for studying m6A modification in osteosarcoma cells. This protocol holds great potential for elucidating m6A regulatory networks and identifying novel therapeutic targets.

Introduction

The latest epitranscriptome research reveals that RNA N6-methyladenosine (m6A) modification, the methylation of N6 position on adenosine, is the most abundant known intrinsic chemical modification of mRNA in eukaryotic cells1. m6A is involved in a wide range of biological processes, including mRNA stability, splicing, nuclear export, and translation efficiency2. Importantly, accumulating evidence suggests that dysregulation of m6A modification contributes to the initiation and development of various cancers, including osteosarcoma, a highly aggressive malignant bone ....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparing the RNA

NOTE: RNA Extraction is performed using an RNA extraction kit. Work inside a clean biosafety cabinet when handling cells and RNA reagents. Wear appropriate personal protective equipment (lab coat, gloves, protective eyewear). Pre-cool the centrifuge to 4 °C before starting.

  1. Prepare the cells.
    1. Remove the culture medium from the 3.5 cm dish and gently wash the cells once with pre-chilled PBS. Add an appropriate volume of RNA lysis buffer directly to the dish to fully lyse the cells and gently pipette to homogenize.
    2. Transfer the cell suspension into a 1.5 mL microcen....

Access restricted. Please log in or start a trial to view this content.

Results

Here we provide a representative result of MeRIP-qPCR analysis, the m6A modification level of c-Myc in hFOB1.19 and 143B cells. As shown in Figure 2, c-Myc enrichment with anti-m6A antibody was significantly higher compared to IgG control, which only showed background levels, suggesting that the anti-m6A antibody is both effective and specific. We also observed that the m6A modification level of c-Myc was significantly higher in 143B than in hFOB1........

Access restricted. Please log in or start a trial to view this content.

Discussion

MeRIP-qPCR has emerged as a valuable tool for studying RNA m6A modifications with broad applications. It is particularly useful in validating high-throughput sequencing results and localizing modification sites precisely within specific regions of target genes during mechanistic studies. Furthermore, this method can be readily implemented in most molecular biology laboratories due to its relatively low cost and operational simplicity, making it an efficient and practical approach for epitranscriptomic research.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This study was supported by grants from National Nature Science Foundation (82174408, 82374477, 82474535 and 82205145).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
100% ethanolShanghai Titan Scientific Co.,Ltd., America1158566
143BATCC, AmericaATCC CRL-8303TM
2×SYBR Green qPCR MixBeijing Qihengxing Biotechnology Co., Ltd., ChinaFS-Q1002
Denovix DS-11 DenovixDS-11 Spectrophotometer
DMEM mediumWISENT CORPORATION, China319-005-CL
DMEM/F-12 mediumGibco, America11320033
EpiQuik CUT&RUN m6A RNA Enrichment (MeRIP) KitEpigentek, AmericaP-9018-24
Fetal Bovine SerumWISENT CORPORATION, China086-150
hFOB1.19Cell Bank of the Chinese Academy of Sciences, ChinaGNHu14
m6A RNA Methylation Assay KitAbcam, Englandab185912
microRNA Reverse Transcription KitEZBioscience-EZB, AmericaA0010CGQ
Real-Time SystemBIO-RAD, AmericaCFX96
Total RNA Extraction KitEZBioscience-EZB, AmericaB0004DP
TrypLE Express EnzymeGibco, America12604021

References

  1. Ma, S., et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 12 (1), 121(2019).
  2. Zhu, Z. M., Huo, F. C., Zhang, J., Shan, H. J., Pei, D. S. Crosstalk between m6A modification and alternative splicing during ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

RNA ImmunoprecipitationN6-MethyladenosineRNA ExtractionProtein G BeadsAntibody EnrichmentReverse Transcription PCRRNA Fragmentation